Clinical trial
A Prospective, Single-arm, Multi-centre, Observational, Real World Registry to Evaluate Safety and Performance of the BioMime™ Morph Sirolimus Eluting Coronary Stent System for Very Long Coronary Lesions.
NCT02901353 is registered in ClinicalTrials.gov with Meril Life Sciences Pvt. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Single-arm, Multi-centre, Observational, Real World Registry to Evaluate Safety and Performance of the BioMime™ Morph Sirolimus Eluting Coronary Stent System for Very Long Coronary Lesions.
- Lead sponsor
- Meril Life Sciences Pvt. Ltd.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 2, 2017
- Completion date
- December 1, 2022
- Enrollment
- 400 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.